| |
2nd
Quarter 2005 |
2nd
Quarter 2006 |
1st
Half
2005 |
1st
Half
2006 |
| EUR million |
|
|
|
|
| EBIT* |
707 |
878 |
1,693 |
1,955 |
| Income taxes |
(187) |
(286) |
(401) |
(510) |
| Depreciation and amortization |
394 |
430 |
790 |
835 |
| Change in pension provisions |
(25) |
(51) |
(135) |
(182) |
| (Gains) losses on retirements of
noncurrent assets |
(22) |
(7) |
(20) |
(8) |
| Gross cash flow |
867 |
964 |
1,927 |
2,090 |
| Decrease (increase) in inventories |
(113) |
11 |
(331) |
(132) |
| Decrease (increase) in trade accounts
receivable |
414 |
11 |
(536) |
(873) |
| Increase (decrease) in trade accounts
payable |
(89) |
(42) |
(345) |
(270) |
| Changes in other working capital,
other non-cash items |
(99) |
(49) |
(6) |
144 |
| Net cash provided by
(used in) operating activities (net cash flow), continuing
operations |
980 |
895 |
709 |
959 |
| Net cash provided by (used in)
operating activities (net cash flow), discontinued operations |
45 |
107 |
58 |
171 |
| Net cash flow provided
by (used in) operating activities (net cash flow), total |
1,025 |
1,002 |
767 |
1,130 |
| Cash outflows for additions to
property, plant, equipment and intangible assets |
(271) |
(340) |
(452) |
(759) |
| Cash inflows from sales of property,
plant, equipment
and other assets |
16 |
63 |
272 |
83 |
| Cash inflows from sales of investments |
267 |
43 |
1,267 |
69 |
| Cash outflows for acquisitions
less acquired cash |
(5) |
(14,110) |
(2,058) |
(14,130) |
| Interest and dividends received |
334 |
375 |
362 |
482 |
| Cash inflows from marketable securities |
(94) |
133 |
(91) |
227 |
| Net cash provided by (used
in) investing activities (total) |
247 |
(13,836) |
(700) |
(14,028) |
| Capital contributions |
0 |
0 |
0 |
0 |
| Bayer AG dividend and dividend
payments
to minority stockholders/ reimbursements of advance
capital gains tax payments |
(429) |
(692) |
(462) |
(527) |
| Issuances of debt |
177 |
13,493 |
441 |
13,762 |
| Retirements of debt |
(656) |
(20) |
(1,210) |
(413) |
| Interest paid |
(439) |
(461) |
(546) |
(689) |
| Net cash provided by (used
in) financing activities (total) |
(1,347) |
12,320 |
(1,777) |
12,133 |
| Change in cash and cash
equivalents due to business activities (total) |
(75) |
(514) |
(1,710) |
(765) |
| Cash and cash equivalents
at beginning of period |
1,749 |
3,026 |
3,570 |
3,290 |
| Change in cash and cash equivalents
due to changes in scope
of consolidation |
0 |
0 |
(196) |
(2) |
| Changes in cash and cash equivalents
due to exchange rate
movements |
24 |
(21) |
34 |
(32) |
| Cash and cash equivalents at end
of period |
1,698 |
2,491 |
1,698 |
2,491 |
| Marketable securities and other
instruments |
119 |
82 |
119 |
82 |
| Liquid assets as per balance
sheets |
1,817 |
2,573 |
1,817 |
2,573 |
